Healthcare · Pharmaceuticals & Biotechnology
Hester Biosciences Limited (HBL) is a publicly traded Indian animal and poultry vaccines manufacturing company, headquartered in Ahmedabad. Hester has plants situated in Gujarat and Nepal. Hester has a 30% share of the poultry vaccines market in India, making it the country's second largest poultry vaccine manufacturer. Hester is also the first commercial manufacturer of goat pox vaccine in India and manufactures PPR vaccines from both, Nigerian and Sungri strains.
Source: Wikipedia
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 300† | 291† | 289† | 259† | 224† |
| Net profit | 52 | 32 | 27 | 32 | 40† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| Priya Gandhi | Executive Director | June 30, 2026 |
| Rajiv Dinesh Gandhi | Executive Director | June 30, 2026 |
| Ameet Hiranyakumar Desai | Independent Director | June 30, 2026 |
| Anil Jain | Independent Director | June 30, 2026 |
| Ashok Bhhimarao Bhadakal | Independent Director | June 30, 2026 |
| Jatin Trivedi | Independent Director | June 30, 2026 |
| Sandhya Maulik Patel | Independent Director | June 30, 2026 |
| Bhupendra Vittaldas Gandhi | Non-Executive Director | June 30, 2026 |
| Sanjiv Dinesh Gandhi | Non-Executive Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.